Our opinions are our own. It can deliver value to Delta devotees, but thanks to its increased annual fee, it's not the no-brainer it used to be.

It's a luxury card for those who fly frequently with Delta and can maximize the card's rich benefits. Those seeking a lower annual fee and more flexibility have other options.

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...